MONTVALE, N.J., April 14 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY), a biopharmaceutical company, today announced that they
will host an R&D Day on Friday, April 21st, at 8.30 a.m. E.T., at the W New
York Hotel in New York City.
Interested parties may access a live webcast of the presentation and
accompanying slides by visiting the Investor Relations section of Memory
Pharmaceuticals' website at http://www.memorypharma.com. An archived version
of the webcast will be available at the same location through April 28, 2006.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 04/14/2006
/CONTACT: Jzaneen Lalani, Vice President, Legal Affairs of Memory
Pharmaceuticals Corp., +1-201-802-7249, or Laura Perry of Stern Investor
Relations, Inc., +1-212-362-1200, for Memory Pharmaceuticals Corp./
/Web site: http://www.memorypharmaceuticals.com
http://www.memorypharma.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey, New York
IN: HEA MTC BIO
SU: CCA MAV TDS
EM
-- NYF006 --
9831 04/14/2006 07:00 EDT http://www.prnewswire.com
